FDA Medical Device Labeling (21 CFR Part 801)

FDA Medical Device Labeling (21 CFR Part 801) sets the mandatory requirements for labeling medical devices marketed in the United States. Compliance with FDA Medical Device Labeling (21 CFR Part 801) ensures that devices clearly communicate intended use, safety information, manufacturer details, and traceability elements such as UDI. Proper adherence to FDA Medical Device Labeling (21 CFR Part 801) is essential for regulatory approval, patient safety, and market credibility.

Key Requirements Under FDA Medical Device Labeling (21 CFR Part 801)

• General Labeling: Must include manufacturer name, address, and role (if distributed or repacked).

• Intended Use & Safety: Clear directions, warnings, precautions, and risk information.

• Unique Device Identification (UDI): Most devices require UDI in both human-readable and machine-readable formats; reusable and software devices have specific UDI obligations.

• OTC & Prescription Devices: OTC devices need consumer-friendly instructions; prescription devices must state “Rx only.”

• Exemptions: Certain custom, investigational, research, or export-only devices may qualify for labeling exemptions.

Best Practices

• Define intended use clearly

• Integrate UDI early in design and QMS

• Use standardized symbols (ISO 15223-1)

• Continuously review labeling through post-market surveillance

Incorporating FDA Medical Device Labeling (21 CFR Part 801) into your quality system ensures compliance, strengthens product trust, and supports successful U.S. market entry.